Marian Jarlenski1, Jill A Tarr2, Cynthia L Holland2, David Farrell3, Judy C Chang4. 1. Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania. Electronic address: marian.jarlenski@pitt.edu. 2. Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania. 3. People Designs, Durham, North Carolina. 4. Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; Departments of Obstetrics, Gynecology and Reproductive Sciences and Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: Marijuana is the most commonly used illicit substance in pregnancy. Little is known about how pregnant women who use marijuana obtain and understand information about perinatal marijuana use. We conducted a qualitative study among pregnant women who had used marijuana to understand their information-seeking patterns and perceptions of usefulness of available information about perinatal marijuana use. STUDY DESIGN: We conducted semistructured interviews with 26 pregnant women who were receiving prenatal care and who either disclosed marijuana use or had urine samples testing positive for marijuana. Interviews assessed women's sources of information about risks of perinatal marijuana use and perceptions regarding the usefulness of such information. Interview data were coded independently by two coders who iteratively refined the codes and reviewed transcripts for themes. RESULTS: Commonly reported sources of information about perinatal marijuana use included Internet searching and anecdotal experiences or advice from family or friends. Few women reported receiving helpful information from a health care provider or social worker. Women perceived a lack of evidence about harms of perinatal marijuana use, and reported being dissatisfied with the quality of information. Most women said they desired information about the effects of perinatal marijuana use on infant health. CONCLUSIONS: Women who used marijuana before or during pregnancy did not find available information about perinatal marijuana use to be useful, and sought more information pertaining to infant health and well-being. Efforts to reduce perinatal marijuana use should focus on addressing this need in both clinical and public health settings.
BACKGROUND:Marijuana is the most commonly used illicit substance in pregnancy. Little is known about how pregnant women who use marijuana obtain and understand information about perinatal marijuana use. We conducted a qualitative study among pregnant women who had used marijuana to understand their information-seeking patterns and perceptions of usefulness of available information about perinatal marijuana use. STUDY DESIGN: We conducted semistructured interviews with 26 pregnant women who were receiving prenatal care and who either disclosed marijuana use or had urine samples testing positive for marijuana. Interviews assessed women's sources of information about risks of perinatal marijuana use and perceptions regarding the usefulness of such information. Interview data were coded independently by two coders who iteratively refined the codes and reviewed transcripts for themes. RESULTS: Commonly reported sources of information about perinatal marijuana use included Internet searching and anecdotal experiences or advice from family or friends. Few women reported receiving helpful information from a health care provider or social worker. Women perceived a lack of evidence about harms of perinatal marijuana use, and reported being dissatisfied with the quality of information. Most women said they desired information about the effects of perinatal marijuana use on infant health. CONCLUSIONS:Women who used marijuana before or during pregnancy did not find available information about perinatal marijuana use to be useful, and sought more information pertaining to infant health and well-being. Efforts to reduce perinatal marijuana use should focus on addressing this need in both clinical and public health settings.
Authors: S C Jaques; A Kingsbury; P Henshcke; C Chomchai; S Clews; J Falconer; M E Abdel-Latif; J M Feller; J L Oei Journal: J Perinatol Date: 2014-01-23 Impact factor: 2.521
Authors: Jean Y Ko; Sherry L Farr; Van T Tong; Andreea A Creanga; William M Callaghan Journal: Am J Obstet Gynecol Date: 2015-03-12 Impact factor: 8.661
Authors: Judy C Chang; Cynthia L Holland; Jill A Tarr; Doris Rubio; Keri L Rodriguez; Kevin L Kraemer; Nancy Day; Robert M Arnold Journal: Am J Health Promot Date: 2016-11-17
Authors: Marian Jarlenski; Jonathan W Koma; Jennifer Zank; Lisa M Bodnar; Jill A Tarr; Judy C Chang Journal: Drug Alcohol Depend Date: 2018-04-11 Impact factor: 4.492
Authors: Kelly C Young-Wolff; Varada Sarovar; Lue-Yen Tucker; Lyndsay A Avalos; Stacey Alexeeff; Amy Conway; Mary Anne Armstrong; Constance Weisner; Cynthia I Campbell; Nancy Goler Journal: Drug Alcohol Depend Date: 2019-01-18 Impact factor: 4.492
Authors: Laura R Stroud; George D Papandonatos; Meaghan McCallum; Tessa Kehoe; Amy L Salisbury; Marilyn A Huestis Journal: Neurotoxicol Teratol Date: 2018-09-26 Impact factor: 3.763
Authors: Judy C Chang; Jill A Tarr; Cynthia L Holland; Natacha M De Genna; Gale A Richardson; Keri L Rodriguez; Jeanelle Sheeder; Kevin L Kraemer; Nancy L Day; Doris Rubio; Marian Jarlenski; Robert M Arnold Journal: Drug Alcohol Depend Date: 2019-01-11 Impact factor: 4.492
Authors: Sarah J Weisbeck; Katherine S Bright; Carla S Ginn; Jacqueline M Smith; K Alix Hayden; Catherine Ringham Journal: Can J Public Health Date: 2020-08-04